Drawing for BRINEURA

USPTO serial 86402304

BRINEURA

Reviewed by CopyMark Law Group

Reg. 5276719Status 702Renewal
Filing date
Status date
Registration date
Aug 29, 2017
Examiner
FATHY, DOMINIC
Law office
TMEG LAW OFFICE 104

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BRINEURA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory J. Chinlund

Gregory J. Chinlund Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 2, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 2, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 2, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 14, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Aug 29, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 9, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 31, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 29, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 27, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 14, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 5, 2017IUAFUSE AMENDMENT FILED—
Jul 5, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2017EX4GSOU EXTENSION 4 GRANTED—
Apr 6, 2017EXT4SOU EXTENSION 4 FILED—
Apr 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 8, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 7, 2016EX3GSOU EXTENSION 3 GRANTED—
Oct 13, 2016EXT3SOU EXTENSION 3 FILED—
Oct 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 10, 2016EX2GSOU EXTENSION 2 GRANTED—
May 7, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 6, 2016EXT2SOU EXTENSION 2 FILED—
Apr 6, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 3, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 1, 2015EX1GSOU EXTENSION 1 GRANTED—
Oct 1, 2015EXT1SOU EXTENSION 1 FILED—
Oct 1, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 7, 2015DOCKASSIGNED TO EXAMINER—
Sep 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance